Home Axonics

Axonics

acquired
Seasoned Equity Offering
Developer of Novel Implantable Neuromodulation Technologies
Basic
Enterprise Profile

Basic Information

Axonics is a company dedicated to developing novel implantable neuromodulation technologies. This novel implantable neuromodulation technology, licensed from The Alfred Mann Foundation, targets numerous clinical indications, including the treatment of chronic pain and overactive bladder.
Axonics, Inc.
California,United States of America
101~500 people
January 01, 2012
--

Enterprise Profile

Industrial Sector
Medical Device R&D and Design Manufacturing of Medical Equipment, Instruments, and Consumables
Technology
Cell Technology Electrophysiological Techniques
Concept
Neurosurgery # Brain Sciences Disease Treatment # Nervous System Diseases Chronic Disease
Application Scenarios
High-Value Medical Consumables